全体要約
医薬品受託製造市場は、2023年に873億5000万米ドルと評価され、2030年には1311億米ドルに達する見込みで、2024年から2030年の間に年平均成長率（CAGR）は5.9%と予測されています。北米が最大の市場で約30%のシェアを占め、次いで欧州と中国が同様に約30%のシェアを持っています。APIが最大のセグメントで、全体の約75%を占めています。
主要企業にはCatalent、Thermo Fisher Scientific、Lonza、Boehringer Ingelheim、Farevaなどがあり、上位5社で約10%のシェアを保持しています。市場は大企業向けのアプリケーションが最も大きく、小規模企業が続きます。市場は地域別、製品タイプ別、アプリケーション別に詳細にセグメント化されています。
関連する質問
87350百万米ドル（2023年）
5.9%（2024年-2030年）
Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva
API生産の需要増加, 大企業向けの製造サービス, 技術革新と新製品開発
概要
2023年の契約医薬品製造の世界市場は、873億5000万米ドルと推定されており、2030年までには再調整された規模で1311億ドルに達すると予測され、2024年から2030年までの予測期間中の年平均成長率（CAGR）は5.9%です。
グローバル契約医薬品製造の主要プレーヤーには、カタレント、セルモフィッシャーサイエンティフィック、ロンザ、ボーリンガーインゲルハイム、ファレバなどが含まれます。グローバルトップ5のプレーヤーは約10%のシェアを持っています。
北アメリカは最大の市場で、約30％のシェアを持っています。次いでヨーロッパと中国があり、合計で約30％のシェアを持っています。
製品の観点では、APIが最大のセグメントであり、そのシェアは約75%です。また、アプリケーションの観点では、最大のアプリケーションは大企業であり、その後に中小企業があります。
レポートの範囲
この報告書は、契約製薬製造の世界市場について、定量的および定性的な分析を通じて包括的なプレゼンテーションを提供することを目的としており、読者がビジネス/成長戦略を策定し、市場の競争状況を評価し、現在の市場での自社の位置を分析し、契約製薬製造に関する情報に基づいたビジネス意思決定を行うのを助けます。
契約製薬製造市場の規模、見積もり、予測は、2023年を基準年とし、2019年から2030年までの期間の履歴および予測データに基づいて、収益（百万ドル）として提供されます。この報告書は、グローバルな契約製薬製造市場を包括的にセグメント化しています。製品の種類、用途、プレーヤー別の地域市場規模も提供されています。
市場をより深く理解するために、報告書では競争環境のプロフィール、主要競合他社、およびそれぞれの市場順位を提供。また、報告書では技術的トレンドや新製品開発についても論じています。
この報告書は、契約製薬製造会社、新規参入者、及びこの市場に関連する業界チェーンの企業に、全体市場と異なるセグメントにおけるサブセグメントの収益情報を提供します。これには、会社、製品タイプ、用途、地域別の情報が含まれます。
市場セグメンテーション
会社別
カタレント
DPx
ロンザ
ピラマル・ヘルスケア
アエノバ
陽気な
ファマール
ベーリンガーインゲルハイム
ファレバ・ホールディング
アッヴィ
ニプロ株式会社
ヴェッター
ソファーマ
DPTラボラトリーズ
レシファーム
ネクストファーマ
ディッシュマン
エセイカ
タイプ別セグメント
口腔の
注射可能な
API
他の
アプリケーション別セグメント
大企業
中小企業
地域別
北米
アメリカ合衆国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧諸国
その他のヨーロッパ
アジア太平洋
中国
日本
韓国
インド
東南アジア
オーストラリア
アジア太平洋のその他
ラテンアメリカ
メキシコ
ブラジル
ラテンアメリカその他
中東とアフリカ
トルコ
サウジアラビア
UAE（アラブ首長国連邦）
中東・アフリカのその他
章のアウトライン
第1章：レポートの範囲を紹介し、異なる市場セグメント（製品タイプ、アプリケーションなど）のエグゼクティブサマリーを提供します。また、各市場セグメントの市場規模、将来の発展可能性なども含まれています。
第2章：グローバルおよび地域レベルにおける契約医薬品製造の収益。
第3章：契約薬品製造会社の競争環境、収益、市場シェアと業界ランキング、最新の開発計画、合併および買収情報などの詳細分析です。
第4章：主要企業のプロフィールを提供し、市場における主要企業の基本的な状況を詳細に紹介します。これには、製品の説明や仕様、契約医薬品製造の収益、粗利益、最近の開発などが含まれます。
第5章：様々な市場セグメントをタイプ別に分析し、各市場セグメントの収益と開発の可能性をカバーしています。これにより、読者は異なる市場セグメントにおけるブルーオーシャン市場を見つける手助けをします。
第6章：アプリケーション別のさまざまな市場セグメントの分析を提供し、各市場セグメントの収益と発展の可能性をカバーし、読者がさまざまな下流市場におけるブルーオーシャン市場を見つける手助けをします。
第7章：北アメリカ（米国とカナダ）タイプ別、用途別、国別、各セグメントの収益。
第8章：タイプ別、用途別、国別のヨーロッパ、各セグメントの収益。
第9章：アジア太平洋地域、タイプ別、アプリケーション別、地域別、各セグメントの収益。
第10章：ラテンアメリカの種類別、用途別、および国別、各セグメントの収益。
第11章: 中東およびアフリカ、タイプ別、アプリケーション別、国別、各セグメントの収益。
第12章：産業チェーン、販売チャネル、主要原材料、流通業者、および顧客の分析です。
第13章：市場のダイナミクス、最新の市場動向、市場の推進要因と制約要因、業界のメーカーが直面する課題とリスク、さらに業界の関連政策の分析を紹介します。
第14章：研究結果と結論
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査のカバー範囲
1.1 医薬品受託製造 : プロダクトのイントロダクション
1.2 市場、タイプ別
1.2.1 グローバルにおける医薬品受託製造市場規模成長率、タイプ別（2019年 vs 2023年 vs 2030年）
1.2.2 オーラル
1.2.3 インジェクタブル
1.2.4 API
1.2.5 その他
1.3 市場、用途別
1.3.1 グローバルにおける医薬品受託製造市場規模成長率、用途別（2019年 vs 2023年 vs 2030年）
1.3.2 大企業
1.3.3 中小企業
1.4 前提条件と限界
1.5 調査の目的
1.6 対象年
2 エグゼクティブサマリー
2.1 グローバルにおける医薬品受託製造市場規模の見積もりと予測
2.2 医薬品受託製造市場規模、地域別：2023年と2030年の比較
2.2.1 グローバルにおける医薬品受託製造市場の収益規模、地域別 2019年～2024年
2.2.2 グローバルの医薬品受託製造収益、市場予測（地域別）（2025年～2030年）
2.2.3 グローバルにおける医薬品受託製造市場の収益シェア、地域別（2019年～2030年）
3 グローバルにおける医薬品受託製造、企業別
3.1 グローバルにおける医薬品受託製造市場の収益規模、企業別（2019年～2024年）
3.2 グローバルにおける医薬品受託製造市場の収益シェア、企業別（2019年〜2024年）
3.3 競合情勢
3.3.1 Key Contract Pharmaceutical Manufacturing Companies around the World: Ranking by Revenue
3.3.2 Global Contract Pharmaceutical Manufacturing Market Concentration Ratio \(CR5 and HHI\) & \(2019-2024\)
3.3.3 Global Contract Pharmaceutical Manufacturing Market Share by Company Type \(Tier 1, Tier 2 and Tier 3\)
3.4 グローバルにおける医薬品受託製造の会社所在地と製品タイプ
3.4.1 医薬品受託製造の会社所在地
3.4.2 グローバルにおける医薬品受託製造の製品・サービス
3.4.3 国際企業の医薬品受託製造市場への参入日
3.5 グローバルにおける医薬品受託製造のM&A、事業拡張計画
4 企業プロファイル
4.1 Catalent
4.1.1 Catalent：企業情報
4.1.2 Catalent：会社概要、事業概要
4.1.3 Catalent：医薬品受託製造の製品
4.1.4 Catalent：医薬品受託製造の収益および売上総利益率（2019年〜2024年）
4.1.5 Catalent：製品別の医薬品受託製造の収益（2023年）
4.1.6 Catalent：用途別の医薬品受託製造の収益（2023年）
4.1.7 Catalent：地理別の医薬品受託製造の収益（2023年）
4.1.8 Catalent：近況
4.2 DPx
4.2.1 DPx：企業情報
4.2.2 DPx：会社概要、事業概要
4.2.3 DPx：医薬品受託製造の製品
4.2.4 DPx：医薬品受託製造の収益および売上総利益率（2019年〜2024年）
4.2.5 DPx：製品別の医薬品受託製造の収益（2023年）
4.2.6 DPx：用途別の医薬品受託製造の収益（2023年）
4.2.7 DPx：地理別の医薬品受託製造の収益（2023年）
4.2.8 DPx：近況
4.3 Lonza
4.3.1 Lonza：企業情報
4.3.2 Lonza：会社概要、事業概要
4.3.3 Lonza：医薬品受託製造の製品
4.3.4 Lonza：医薬品受託製造の収益および売上総利益率（2019年〜2024年）
4.3.5 Lonza：製品別の医薬品受託製造の収益（2023年）
4.3.6 Lonza：用途別の医薬品受託製造の収益（2023年）
4.3.7 Lonza：地理別の医薬品受託製造の収益（2023年）
4.3.8 Lonza：近況
4.4 Piramal Healthcare
4.4.1 Piramal Healthcare：企業情報
4.4.2 Piramal Healthcare：会社概要、事業概要
4.4.3 Piramal Healthcare：医薬品受託製造の製品
4.4.4 Piramal Healthcare：医薬品受託製造の収益および売上総利益率（2019年〜2024年）
4.4.5 Piramal Healthcare：製品別の医薬品受託製造の収益（2023年）
4.4.6 Piramal Healthcare：用途別の医薬品受託製造の収益（2023年）
4.4.7 Piramal Healthcare：地理別の医薬品受託製造の収益（2023年）
4.4.8 Piramal Healthcare：近況
4.5 Aenova
4.5.1 Aenova：企業情報
4.5.2 Aenova：会社概要、事業概要
4.5.3 Aenova：医薬品受託製造の製品
4.5.4 Aenova：医薬品受託製造の収益および売上総利益率（2019年〜2024年）
4.5.5 Aenova：製品別の医薬品受託製造の収益（2023年）
4.5.6 Aenova：用途別の医薬品受託製造の収益（2023年）
4.5.7 Aenova：地理別の医薬品受託製造の収益（2023年）
4.5.8 Aenova：近況
4.6 Jubilant
4.6.1 Jubilant：企業情報
4.6.2 Jubilant：会社概要、事業概要
4.6.3 Jubilant：医薬品受託製造の製品
4.6.4 Jubilant：医薬品受託製造の収益および売上総利益率（2019年〜2024年）
4.6.5 Jubilant：製品別の医薬品受託製造の収益（2023年）
4.6.6 Jubilant：用途別の医薬品受託製造の収益（2023年）
4.6.7 Jubilant：地理別の医薬品受託製造の収益（2023年）
4.6.8 Jubilant直近の動向
4.7 Famar
4.7.1 Famar：企業情報
4.7.2 Famar：会社概要、事業概要
4.7.3 Famar：医薬品受託製造の製品
4.7.4 Famar：医薬品受託製造の収益および売上総利益率（2019年〜2024年）
4.7.5 Famar：製品別の医薬品受託製造の収益（2023年）
4.7.6 Famar：用途別の医薬品受託製造の収益（2023年）
4.7.7 Famar：地理別の医薬品受託製造の収益（2023年）
4.7.8 Famar直近の動向
4.8 Boehringer Ingelheim
4.8.1 Boehringer Ingelheim：企業情報
4.8.2 Boehringer Ingelheim：会社概要、事業概要
4.8.3 Boehringer Ingelheim：医薬品受託製造の製品
4.8.4 Boehringer Ingelheim：医薬品受託製造の収益および売上総利益率（2019年〜2024年）
4.8.5 Boehringer Ingelheim：製品別の医薬品受託製造の収益（2023年）
4.8.6 Boehringer Ingelheim：用途別の医薬品受託製造の収益（2023年）
4.8.7 Boehringer Ingelheim：地理別の医薬品受託製造の収益（2023年）
4.8.8 Boehringer Ingelheim直近の動向
4.9 Fareva Holding
4.9.1 Fareva Holding：企業情報
4.9.2 Fareva Holding：会社概要、事業概要
4.9.3 Fareva Holding：医薬品受託製造の製品
4.9.4 Fareva Holding：医薬品受託製造の収益および売上総利益率（2019年〜2024年）
4.9.5 Fareva Holding：製品別の医薬品受託製造の収益（2023年）
4.9.6 Fareva Holding：用途別の医薬品受託製造の収益（2023年）
4.9.7 Fareva Holding：地理別の医薬品受託製造の収益（2023年）
4.9.8 Fareva Holding直近の動向
4.10 AbbVie
4.10.1 AbbVie：企業情報
4.10.2 AbbVie：会社概要、事業概要
4.10.3 AbbVie：医薬品受託製造の製品
4.10.4 AbbVie：医薬品受託製造の収益および売上総利益率（2019年〜2024年）
4.10.5 AbbVie：製品別の医薬品受託製造の収益（2023年）
4.10.6 AbbVie：用途別の医薬品受託製造の収益（2023年）
4.10.7 AbbVie：地理別の医薬品受託製造の収益（2023年）
4.10.8 AbbVie直近の動向
4.11 Nipro Corp
4.11.1 Nipro Corp：企業情報
4.11.2 Nipro Corp：会社概要、事業概要
4.11.3 Nipro Corp：医薬品受託製造の製品
4.11.4 Nipro Corp：医薬品受託製造の収益および売上総利益率（2019年〜2024年）
4.11.5 Nipro Corp：製品別の医薬品受託製造の収益（2023年）
4.11.6 Nipro Corp：用途別の医薬品受託製造の収益（2023年）
4.11.7 Nipro Corp：地理別の医薬品受託製造の収益（2023年）
4.11.8 Nipro Corp直近の動向
4.12 Vetter
4.12.1 Vetter：企業情報
4.12.2 Vetter：会社概要、事業概要
4.12.3 Vetter：医薬品受託製造の製品
4.12.4 Vetter：医薬品受託製造の収益および売上総利益率（2019年〜2024年）
4.12.5 Vetter：製品別の医薬品受託製造の収益（2023年）
4.12.6 Vetter：用途別の医薬品受託製造の収益（2023年）
4.12.7 Vetter：地理別の医薬品受託製造の収益（2023年）
4.12.8 Vetter直近の動向
4.13 Sopharma
4.13.1 Sopharma：企業情報
4.13.2 Sopharma：会社概要、事業概要
4.13.3 Sopharma：医薬品受託製造の製品
4.13.4 Sopharma：医薬品受託製造の収益および売上総利益率（2019年〜2024年）
4.13.5 Sopharma：製品別の医薬品受託製造の収益（2023年）
4.13.6 Sopharma：用途別の医薬品受託製造の収益（2023年）
4.13.7 Sopharma：地理別の医薬品受託製造の収益（2023年）
4.13.8 Sopharma直近の動向
4.14 DPT Laboratories
4.14.1 DPT Laboratories：企業情報
4.14.2 DPT Laboratories：会社概要、事業概要
4.14.3 DPT Laboratories：医薬品受託製造の製品
4.14.4 DPT Laboratories：医薬品受託製造の収益および売上総利益率（2019年〜2024年）
4.14.5 DPT Laboratories：製品別の医薬品受託製造の収益（2023年）
4.14.6 DPT Laboratories：用途別の医薬品受託製造の収益（2023年）
4.14.7 DPT Laboratories：地理別の医薬品受託製造の収益（2023年）
4.14.8 DPT Laboratories直近の動向
4.15 Recipharm
4.15.1 Recipharm：企業情報
4.15.2 Recipharm：会社概要、事業概要
4.15.3 Recipharm：医薬品受託製造の製品
4.15.4 Recipharm：医薬品受託製造の収益および売上総利益率（2019年〜2024年）
4.15.5 Recipharm：製品別の医薬品受託製造の収益（2023年）
4.15.6 Recipharm：用途別の医薬品受託製造の収益（2023年）
4.15.7 Recipharm：地理別の医薬品受託製造の収益（2023年）
4.15.8 Recipharm直近の動向
4.16 NextPharma
4.16.1 NextPharma：企業情報
4.16.2 NextPharma：会社概要、事業概要
4.16.3 NextPharma：医薬品受託製造の製品
4.16.4 NextPharma：医薬品受託製造の収益および売上総利益率（2019年〜2024年）
4.16.5 NextPharma：製品別の医薬品受託製造の収益（2023年）
4.16.6 NextPharma：用途別の医薬品受託製造の収益（2023年）
4.16.7 NextPharma：地理別の医薬品受託製造の収益（2023年）
4.16.8 NextPharma直近の動向
4.17 Dishman
4.17.1 Dishman：企業情報
4.17.2 Dishman：会社概要、事業概要
4.17.3 Dishman：医薬品受託製造の製品
4.17.4 Dishman：医薬品受託製造の収益および売上総利益率（2019年〜2024年）
4.17.5 Dishman：製品別の医薬品受託製造の収益（2023年）
4.17.6 Dishman：用途別の医薬品受託製造の収益（2023年）
4.17.7 Dishman：地理別の医薬品受託製造の収益（2023年）
4.17.8 Dishman直近の動向
4.18 Aesica
4.18.1 Aesica：企業情報
4.18.2 Aesica：会社概要、事業概要
4.18.3 Aesica：医薬品受託製造の製品
4.18.4 Aesica：医薬品受託製造の収益および売上総利益率（2019年〜2024年）
4.18.5 Aesica：製品別の医薬品受託製造の収益（2023年）
4.18.6 Aesica：用途別の医薬品受託製造の収益（2023年）
4.18.7 Aesica：地理別の医薬品受託製造の収益（2023年）
4.18.8 Aesica直近の動向
5 ブレークダウンデータ、タイプ別
5.1 グローバルにおける医薬品受託製造市場の収益規模、タイプ別（2019年～2024年）
5.2 グローバルの医薬品受託製造収益、市場予測（タイプ別）（2025年～2030年）
5.3 医薬品受託製造の収益と市場シェア、タイプ別（2019年〜2030年）
6 ブレークダウンデータ、用途別
6.1 グローバルにおける医薬品受託製造市場の収益規模、用途別（2019年～2024年）
6.2 グローバルの医薬品受託製造収益、市場予測（用途別）（2025年～2030年）
6.3 医薬品受託製造の収益と市場シェア、用途別（2019年〜2030年）
7 北米
7.1 北米における医薬品受託製造市場規模の前年比成長率、2019年〜2030年
7.2 北米における医薬品受託製造市場のファクト・数値、 国別（2019年〜2030年）
7.3 北米における医薬品受託製造市場の収益規模、タイプ別（2019年～2024年）
7.4 北米における医薬品受託製造市場の収益規模、用途別（2019年～2024年）
8 アジア太平洋
8.1 アジア太平洋における医薬品受託製造市場規模の前年比成長率、2019年〜2030年
8.2 アジア太平洋における医薬品受託製造市場のファクト・数値、 地域別（2019年〜2030年）
8.3 アジア太平洋における医薬品受託製造市場の収益規模、タイプ別（2019年～2024年）
8.4 アジア太平洋における医薬品受託製造市場の収益規模、用途別（2019年～2024年）
9 ヨーロッパ
9.1 ヨーロッパにおける医薬品受託製造市場規模の前年比成長率、2019年〜2030年
9.2 ヨーロッパにおける医薬品受託製造市場のファクト・数値、 国別（2019年〜2030年）
9.3 ヨーロッパにおける医薬品受託製造市場の収益規模、タイプ別（2019年～2024年）
9.4 ヨーロッパにおける医薬品受託製造市場の収益規模、用途別（2019年～2024年）
10 ラテンアメリカ
10.1 ラテンアメリカにおける医薬品受託製造市場規模の前年比成長率、2019年〜2030年
10.2 ラテンアメリカにおける医薬品受託製造市場のファクト・数値、 国別（2019年〜2030年）
10.3 ラテンアメリカにおける医薬品受託製造市場の収益規模、タイプ別（2019年～2024年）
10.4 ラテンアメリカにおける医薬品受託製造市場の収益規模、用途別（2019年～2024年）
11 中東・アフリカ
11.1 中東・アフリカにおける医薬品受託製造市場規模の前年比成長率、2019年〜2030年
11.2 中東・アフリカにおける医薬品受託製造市場のファクト・数値、 国別（2019年〜2030年）
11.3 中東・アフリカにおける医薬品受託製造市場の収益規模、タイプ別（2019年～2024年）
11.4 中東・アフリカにおける医薬品受託製造市場の収益規模、用途別（2019年～2024年）
12 サプライチェーンと販売チャネル分析
12.1 医薬品受託製造サプライチェーン分析
12.2 医薬品受託製造の主要原材料と上流サプライヤー
12.3 医薬品受託製造の顧客分析
12.4 医薬品受託製造の販売チャネルと販売モデルの分析
12.4.1 医薬品受託製造の流通チャネル分析： 間接販売 VS 直接販売
12.4.2 医薬品受託製造の流通チャネル分析： オンライン販売 VS オフライン販売
12.4.3 医薬品受託製造の流通業者
13 市場ダイナミクス
13.1 医薬品受託製造業界トレンド
13.2 医薬品受託製造市場のドライバー
13.3 医薬品受託製造市場の課題
13.4 医薬品受託製造市場の抑制要因
14 調査の結果・結論
15 付録
15.1 調査手法
15.1.1 調査手法 / 調査アプローチ
15.1.2 データソース
15.2 執筆者の詳細
15.3 免責事項
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
The global market for Contract Pharmaceutical Manufacturing was estimated to be worth US$ 87350 million in 2023 and is forecast to a readjusted size of US$ 131100 million by 2030 with a CAGR of 5.9% during the forecast period 2024-2030.
Global Contract Pharmaceutical Manufacturing key players include Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, etc. Global top five players hold a share about 10%.
North America is the largest market, with a share about 30%, followed by Europe and China, having a total share about 30 percent.
In terms of product, API is the largest segment, with a share about 75%. And in terms of application, the largest application is Large Enterprise, followed by Small Medium Enterprise.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Contract Pharmaceutical Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Contract Pharmaceutical Manufacturing.
The Contract Pharmaceutical Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Contract Pharmaceutical Manufacturing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contract Pharmaceutical Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Catalent
DPx
Lonza
Piramal Healthcare
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie
Nipro Corp
Vetter
Sopharma
DPT Laboratories
Recipharm
NextPharma
Dishman
Aesica
Segment by Type
Oral
Injectable
API
Other
Segment by Application
Large Enterprise
Small Medium Enterprise
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Contract Pharmaceutical Manufacturing in global and regional level.
Chapter 3: Detailed analysis of Contract Pharmaceutical Manufacturing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Contract Pharmaceutical Manufacturing revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Study Coverage
1.1 Contract Pharmaceutical Manufacturing Product Introduction
1.2 Market by Type
1.2.1 Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Oral
1.2.3 Injectable
1.2.4 API
1.2.5 Other
1.3 Market by Application
1.3.1 Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Large Enterprise
1.3.3 Small Medium Enterprise
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Contract Pharmaceutical Manufacturing Market Size Estimates and Forecasts
2.2 Contract Pharmaceutical Manufacturing Market Size by Region: 2023 Versus 2030
2.2.1 Global Contract Pharmaceutical Manufacturing Revenue by Region: 2019-2024
2.2.2 Global Contract Pharmaceutical Manufacturing Revenue Forecast by Region (2025-2030)
2.2.3 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Region (2019-2030)
3 Global Contract Pharmaceutical Manufacturing by Company
3.1 Global Contract Pharmaceutical Manufacturing Revenue by Company (2019-2024)
3.2 Global Contract Pharmaceutical Manufacturing Revenue Share by Company (2019-2024)
3.3 Competitive Landscape
3.3.1 Key Contract Pharmaceutical Manufacturing Companies around the World: Ranking by Revenue
3.3.2 Global Contract Pharmaceutical Manufacturing Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.3.3 Global Contract Pharmaceutical Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Contract Pharmaceutical Manufacturing Companies Headquarters & Product Type
3.4.1 Contract Pharmaceutical Manufacturing Companies Headquarters
3.4.2 Global Contract Pharmaceutical Manufacturing Companies Product & Service
3.4.3 Date of International Companies Enter into Contract Pharmaceutical Manufacturing Market
3.5 Global Contract Pharmaceutical Manufacturing Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Catalent
4.1.1 Catalent Company Information
4.1.2 Catalent Description, Business Overview
4.1.3 Catalent Contract Pharmaceutical Manufacturing Products Offered
4.1.4 Catalent Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
4.1.5 Catalent Contract Pharmaceutical Manufacturing Revenue by Product in 2023
4.1.6 Catalent Contract Pharmaceutical Manufacturing Revenue by Application in 2023
4.1.7 Catalent Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
4.1.8 Catalent Recent Developments
4.2 DPx
4.2.1 DPx Company Information
4.2.2 DPx Description, Business Overview
4.2.3 DPx Contract Pharmaceutical Manufacturing Products Offered
4.2.4 DPx Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
4.2.5 DPx Contract Pharmaceutical Manufacturing Revenue by Product in 2023
4.2.6 DPx Contract Pharmaceutical Manufacturing Revenue by Application in 2023
4.2.7 DPx Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
4.2.8 DPx Recent Developments
4.3 Lonza
4.3.1 Lonza Company Information
4.3.2 Lonza Description, Business Overview
4.3.3 Lonza Contract Pharmaceutical Manufacturing Products Offered
4.3.4 Lonza Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
4.3.5 Lonza Contract Pharmaceutical Manufacturing Revenue by Product in 2023
4.3.6 Lonza Contract Pharmaceutical Manufacturing Revenue by Application in 2023
4.3.7 Lonza Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
4.3.8 Lonza Recent Developments
4.4 Piramal Healthcare
4.4.1 Piramal Healthcare Company Information
4.4.2 Piramal Healthcare Description, Business Overview
4.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Products Offered
4.4.4 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
4.4.5 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue by Product in 2023
4.4.6 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue by Application in 2023
4.4.7 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
4.4.8 Piramal Healthcare Recent Developments
4.5 Aenova
4.5.1 Aenova Company Information
4.5.2 Aenova Description, Business Overview
4.5.3 Aenova Contract Pharmaceutical Manufacturing Products Offered
4.5.4 Aenova Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
4.5.5 Aenova Contract Pharmaceutical Manufacturing Revenue by Product in 2023
4.5.6 Aenova Contract Pharmaceutical Manufacturing Revenue by Application in 2023
4.5.7 Aenova Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
4.5.8 Aenova Recent Developments
4.6 Jubilant
4.6.1 Jubilant Company Information
4.6.2 Jubilant Description, Business Overview
4.6.3 Jubilant Contract Pharmaceutical Manufacturing Products Offered
4.6.4 Jubilant Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
4.6.5 Jubilant Contract Pharmaceutical Manufacturing Revenue by Product in 2023
4.6.6 Jubilant Contract Pharmaceutical Manufacturing Revenue by Application in 2023
4.6.7 Jubilant Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
4.6.8 Jubilant Recent Development
4.7 Famar
4.7.1 Famar Company Information
4.7.2 Famar Description, Business Overview
4.7.3 Famar Contract Pharmaceutical Manufacturing Products Offered
4.7.4 Famar Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
4.7.5 Famar Contract Pharmaceutical Manufacturing Revenue by Product in 2023
4.7.6 Famar Contract Pharmaceutical Manufacturing Revenue by Application in 2023
4.7.7 Famar Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
4.7.8 Famar Recent Development
4.8 Boehringer Ingelheim
4.8.1 Boehringer Ingelheim Company Information
4.8.2 Boehringer Ingelheim Description, Business Overview
4.8.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Products Offered
4.8.4 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
4.8.5 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue by Product in 2023
4.8.6 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue by Application in 2023
4.8.7 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
4.8.8 Boehringer Ingelheim Recent Development
4.9 Fareva Holding
4.9.1 Fareva Holding Company Information
4.9.2 Fareva Holding Description, Business Overview
4.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Products Offered
4.9.4 Fareva Holding Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
4.9.5 Fareva Holding Contract Pharmaceutical Manufacturing Revenue by Product in 2023
4.9.6 Fareva Holding Contract Pharmaceutical Manufacturing Revenue by Application in 2023
4.9.7 Fareva Holding Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
4.9.8 Fareva Holding Recent Development
4.10 AbbVie
4.10.1 AbbVie Company Information
4.10.2 AbbVie Description, Business Overview
4.10.3 AbbVie Contract Pharmaceutical Manufacturing Products Offered
4.10.4 AbbVie Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
4.10.5 AbbVie Contract Pharmaceutical Manufacturing Revenue by Product in 2023
4.10.6 AbbVie Contract Pharmaceutical Manufacturing Revenue by Application in 2023
4.10.7 AbbVie Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
4.10.8 AbbVie Recent Development
4.11 Nipro Corp
4.11.1 Nipro Corp Company Information
4.11.2 Nipro Corp Description, Business Overview
4.11.3 Nipro Corp Contract Pharmaceutical Manufacturing Products Offered
4.11.4 Nipro Corp Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
4.11.5 Nipro Corp Contract Pharmaceutical Manufacturing Revenue by Product in 2023
4.11.6 Nipro Corp Contract Pharmaceutical Manufacturing Revenue by Application in 2023
4.11.7 Nipro Corp Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
4.11.8 Nipro Corp Recent Development
4.12 Vetter
4.12.1 Vetter Company Information
4.12.2 Vetter Description, Business Overview
4.12.3 Vetter Contract Pharmaceutical Manufacturing Products Offered
4.12.4 Vetter Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
4.12.5 Vetter Contract Pharmaceutical Manufacturing Revenue by Product in 2023
4.12.6 Vetter Contract Pharmaceutical Manufacturing Revenue by Application in 2023
4.12.7 Vetter Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
4.12.8 Vetter Recent Development
4.13 Sopharma
4.13.1 Sopharma Company Information
4.13.2 Sopharma Description, Business Overview
4.13.3 Sopharma Contract Pharmaceutical Manufacturing Products Offered
4.13.4 Sopharma Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
4.13.5 Sopharma Contract Pharmaceutical Manufacturing Revenue by Product in 2023
4.13.6 Sopharma Contract Pharmaceutical Manufacturing Revenue by Application in 2023
4.13.7 Sopharma Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
4.13.8 Sopharma Recent Development
4.14 DPT Laboratories
4.14.1 DPT Laboratories Company Information
4.14.2 DPT Laboratories Description, Business Overview
4.14.3 DPT Laboratories Contract Pharmaceutical Manufacturing Products Offered
4.14.4 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
4.14.5 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue by Product in 2023
4.14.6 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue by Application in 2023
4.14.7 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
4.14.8 DPT Laboratories Recent Development
4.15 Recipharm
4.15.1 Recipharm Company Information
4.15.2 Recipharm Description, Business Overview
4.15.3 Recipharm Contract Pharmaceutical Manufacturing Products Offered
4.15.4 Recipharm Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
4.15.5 Recipharm Contract Pharmaceutical Manufacturing Revenue by Product in 2023
4.15.6 Recipharm Contract Pharmaceutical Manufacturing Revenue by Application in 2023
4.15.7 Recipharm Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
4.15.8 Recipharm Recent Development
4.16 NextPharma
4.16.1 NextPharma Company Information
4.16.2 NextPharma Description, Business Overview
4.16.3 NextPharma Contract Pharmaceutical Manufacturing Products Offered
4.16.4 NextPharma Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
4.16.5 NextPharma Contract Pharmaceutical Manufacturing Revenue by Product in 2023
4.16.6 NextPharma Contract Pharmaceutical Manufacturing Revenue by Application in 2023
4.16.7 NextPharma Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
4.16.8 NextPharma Recent Development
4.17 Dishman
4.17.1 Dishman Company Information
4.17.2 Dishman Description, Business Overview
4.17.3 Dishman Contract Pharmaceutical Manufacturing Products Offered
4.17.4 Dishman Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
4.17.5 Dishman Contract Pharmaceutical Manufacturing Revenue by Product in 2023
4.17.6 Dishman Contract Pharmaceutical Manufacturing Revenue by Application in 2023
4.17.7 Dishman Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
4.17.8 Dishman Recent Development
4.18 Aesica
4.18.1 Aesica Company Information
4.18.2 Aesica Description, Business Overview
4.18.3 Aesica Contract Pharmaceutical Manufacturing Products Offered
4.18.4 Aesica Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
4.18.5 Aesica Contract Pharmaceutical Manufacturing Revenue by Product in 2023
4.18.6 Aesica Contract Pharmaceutical Manufacturing Revenue by Application in 2023
4.18.7 Aesica Contract Pharmaceutical Manufacturing Revenue by Geographic Area in 2023
4.18.8 Aesica Recent Development
5 Breakdown Data by Type
5.1 Global Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024)
5.2 Global Contract Pharmaceutical Manufacturing Revenue Forecast by Type (2025-2030)
5.3 Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024)
6.2 Global Contract Pharmaceutical Manufacturing Revenue Forecast by Application (2025-2030)
6.3 Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2019-2030)
7 North America
7.1 North America Contract Pharmaceutical Manufacturing Market Size YoY Growth 2019-2030
7.2 North America Contract Pharmaceutical Manufacturing Market Facts & Figures by Country (2019-2030)
7.3 North America Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024)
7.4 North America Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Contract Pharmaceutical Manufacturing Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Contract Pharmaceutical Manufacturing Market Facts & Figures by Region (2019-2030)
8.3 Asia-Pacific Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024)
8.4 Asia-Pacific Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024)
9 Europe
9.1 Europe Contract Pharmaceutical Manufacturing Market Size YoY Growth 2019-2030
9.2 Europe Contract Pharmaceutical Manufacturing Market Facts & Figures by Country (2019-2030)
9.3 Europe Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024)
9.4 Europe Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024)
10 Latin America
10.1 Latin America Contract Pharmaceutical Manufacturing Market Size YoY Growth 2019-2030
10.2 Latin America Contract Pharmaceutical Manufacturing Market Facts & Figures by Country (2019-2030)
10.3 Latin America Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024)
10.4 Latin America Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Contract Pharmaceutical Manufacturing Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Contract Pharmaceutical Manufacturing Market Facts & Figures by Country (2019-2030)
11.3 Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024)
11.4 Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Contract Pharmaceutical Manufacturing Supply Chain Analysis
12.2 Contract Pharmaceutical Manufacturing Key Raw Materials and Upstream Suppliers
12.3 Contract Pharmaceutical Manufacturing Clients Analysis
12.4 Contract Pharmaceutical Manufacturing Sales Channel and Sales Model Analysis
12.4.1 Contract Pharmaceutical Manufacturing Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Contract Pharmaceutical Manufacturing Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Contract Pharmaceutical Manufacturing Distributors
13 Market Dynamics
13.1 Contract Pharmaceutical Manufacturing Industry Trends
13.2 Contract Pharmaceutical Manufacturing Market Drivers
13.3 Contract Pharmaceutical Manufacturing Market Challenges
13.4 Contract Pharmaceutical Manufacturing Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables Table 1. Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030 Table 2. Major Companies of Oral Table 3. Major Companies of Injectable Table 4. Major Companies of API Table 5. Major Companies of Other Table 6. Global Contract Pharmaceutical Manufacturing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030 Table 7. Global Contract Pharmaceutical Manufacturing Market Size by Region (US$ Million): 2023 VS 2030 Table 8. Global Contract Pharmaceutical Manufacturing Revenue by Region (2019-2024) & (US$ Million) Table 9. Global Contract Pharmaceutical Manufacturing Revenue Forecast by Region (2025-2030) & (US$ Million) Table 10. Contract Pharmaceutical Manufacturing Revenue by Company (2019-2024) & (US$ Million) Table 11. Contract Pharmaceutical Manufacturing Revenue Share by Company (2019-2024) Table 12. Ranking of Global Top Contract Pharmaceutical Manufacturing Players by Revenue (US$ Million) in 2023 Table 13. Global Contract Pharmaceutical Manufacturing Companies Market Concentration Ratio (CR5 and HHI) & (2019-2024) Table 14. Global Contract Pharmaceutical Manufacturing by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Contract Pharmaceutical Manufacturing as of 2023) Table 15. Global Contract Pharmaceutical Manufacturing Companies Headquarters Table 16. Global Contract Pharmaceutical Manufacturing Companies Product & Service Table 17. Date of International Companies Enter into Contract Pharmaceutical Manufacturing Market Table 18. Global Contract Pharmaceutical Manufacturing Mergers & Acquisitions, Expansion Plans Table 19. Catalent Company Information Table 20. Catalent Description and Business Overview Table 21. Catalent Contract Pharmaceutical Manufacturing Product Table 22. Catalent Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 23. Catalent Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2023 Table 24. Catalent Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2023 Table 25. Catalent Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2023 Table 26. Catalent Recent Development Table 27. DPx Company Information Table 28. DPx Description and Business Overview Table 29. DPx Contract Pharmaceutical Manufacturing Product Table 30. DPx Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 31. DPx Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2023 Table 32. DPx Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2023 Table 33. DPx Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2023 Table 34. DPx Recent Development Table 35. Lonza Company Information Table 36. Lonza Description and Business Overview Table 37. Lonza Contract Pharmaceutical Manufacturing Product Table 38. Lonza Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 39. Lonza Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2023 Table 40. Lonza Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2023 Table 41. Lonza Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2023 Table 42. Lonza Recent Development Table 43. Piramal Healthcare Company Information Table 44. Piramal Healthcare Description and Business Overview Table 45. Piramal Healthcare Contract Pharmaceutical Manufacturing Product Table 46. Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 47. Piramal Healthcare Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2023 Table 48. Piramal Healthcare Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2023 Table 49. Piramal Healthcare Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2023 Table 50. Piramal Healthcare Recent Development Table 51. Aenova Company Information Table 52. Aenova Description and Business Overview Table 53. Aenova Contract Pharmaceutical Manufacturing Product Table 54. Aenova Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 55. Aenova Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2023 Table 56. Aenova Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2023 Table 57. Aenova Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2023 Table 58. Aenova Recent Development Table 59. Jubilant Company Information Table 60. Jubilant Description and Business Overview Table 61. Jubilant Contract Pharmaceutical Manufacturing Product Table 62. Jubilant Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 63. Jubilant Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2023 Table 64. Jubilant Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2023 Table 65. Jubilant Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2023 Table 66. Jubilant Recent Development Table 67. Famar Company Information Table 68. Famar Description and Business Overview Table 69. Famar Contract Pharmaceutical Manufacturing Product Table 70. Famar Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 71. Famar Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2023 Table 72. Famar Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2023 Table 73. Famar Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2023 Table 74. Famar Recent Development Table 75. Boehringer Ingelheim Company Information Table 76. Boehringer Ingelheim Description and Business Overview Table 77. Boehringer Ingelheim Contract Pharmaceutical Manufacturing Product Table 78. Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 79. Boehringer Ingelheim Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2023 Table 80. Boehringer Ingelheim Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2023 Table 81. Boehringer Ingelheim Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2023 Table 82. Boehringer Ingelheim Recent Development Table 83. Fareva Holding Company Information Table 84. Fareva Holding Description and Business Overview Table 85. Fareva Holding Contract Pharmaceutical Manufacturing Product Table 86. Fareva Holding Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 87. Fareva Holding Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2023 Table 88. Fareva Holding Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2023 Table 89. Fareva Holding Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2023 Table 90. Fareva Holding Recent Development Table 91. AbbVie Company Information Table 92. AbbVie Description and Business Overview Table 93. AbbVie Contract Pharmaceutical Manufacturing Product Table 94. AbbVie Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 95. AbbVie Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2023 Table 96. AbbVie Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2023 Table 97. AbbVie Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2023 Table 98. AbbVie Recent Development Table 99. Nipro Corp Company Information Table 100. Nipro Corp Description and Business Overview Table 101. Nipro Corp Contract Pharmaceutical Manufacturing Product Table 102. Nipro Corp Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 103. Nipro Corp Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2023 Table 104. Nipro Corp Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2023 Table 105. Nipro Corp Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2023 Table 106. Nipro Corp Recent Development Table 107. Vetter Company Information Table 108. Vetter Description and Business Overview Table 109. Vetter Contract Pharmaceutical Manufacturing Product Table 110. Vetter Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 111. Vetter Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2023 Table 112. Vetter Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2023 Table 113. Vetter Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2023 Table 114. Vetter Recent Development Table 115. Sopharma Company Information Table 116. Sopharma Description and Business Overview Table 117. Sopharma Contract Pharmaceutical Manufacturing Product Table 118. Sopharma Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 119. Sopharma Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2023 Table 120. Sopharma Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2023 Table 121. Sopharma Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2023 Table 122. Sopharma Recent Development Table 123. DPT Laboratories Company Information Table 124. DPT Laboratories Description and Business Overview Table 125. DPT Laboratories Contract Pharmaceutical Manufacturing Product Table 126. DPT Laboratories Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 127. DPT Laboratories Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2023 Table 128. DPT Laboratories Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2023 Table 129. DPT Laboratories Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2023 Table 130. DPT Laboratories Recent Development Table 131. Recipharm Company Information Table 132. Recipharm Description and Business Overview Table 133. Recipharm Contract Pharmaceutical Manufacturing Product Table 134. Recipharm Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 135. Recipharm Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2023 Table 136. Recipharm Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2023 Table 137. Recipharm Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2023 Table 138. Recipharm Recent Development Table 139. NextPharma Company Information Table 140. NextPharma Description and Business Overview Table 141. NextPharma Contract Pharmaceutical Manufacturing Product Table 142. NextPharma Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 143. NextPharma Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2023 Table 144. NextPharma Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2023 Table 145. NextPharma Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2023 Table 146. NextPharma Recent Development Table 147. Dishman Company Information Table 148. Dishman Description and Business Overview Table 149. Dishman Contract Pharmaceutical Manufacturing Product Table 150. Dishman Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 151. Dishman Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2023 Table 152. Dishman Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2023 Table 153. Dishman Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2023 Table 154. Dishman Recent Development Table 155. Aesica Company Information Table 156. Aesica Description and Business Overview Table 157. Aesica Contract Pharmaceutical Manufacturing Product Table 158. Aesica Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2019-2024) Table 159. Aesica Revenue Proportion of Contract Pharmaceutical Manufacturing by Product in 2023 Table 160. Aesica Revenue Proportion of Contract Pharmaceutical Manufacturing by Application in 2023 Table 161. Aesica Revenue Proportion of Contract Pharmaceutical Manufacturing by Geographic Area in 2023 Table 162. Aesica Recent Development Table 163. Global Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024) & (US$ Million) Table 164. Global Contract Pharmaceutical Manufacturing Revenue Forecast by Type (2025-2030) & (US$ Million) Table 165. Global Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024) & (US$ Million) Table 166. Global Contract Pharmaceutical Manufacturing Revenue Forecast by Application (2025-2030) & (US$ Million) Table 167. North America Contract Pharmaceutical Manufacturing Revenue by Country (2019-2024) & (US$ Million) Table 168. North America Contract Pharmaceutical Manufacturing Revenue by Country (2025-2030) & (US$ Million) Table 169. North America Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024) & (US$ Million) Table 170. North America Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024) & (US$ Million) Table 171. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue by Region (2019-2030) & (US$ Million) Table 172. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue by Region (2025-2030) & (US$ Million) Table 173. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024) & (US$ Million) Table 174. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024) & (US$ Million) Table 175. Europe Contract Pharmaceutical Manufacturing Revenue by Country (2019-2024) & (US$ Million) Table 176. Europe Contract Pharmaceutical Manufacturing Revenue by Country (2025-2030) & (US$ Million) Table 177. Europe Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024) & (US$ Million) Table 178. Europe Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024) & (US$ Million) Table 179. Latin America Contract Pharmaceutical Manufacturing Revenue by Country (2019-2024) & (US$ Million) Table 180. Latin America Contract Pharmaceutical Manufacturing Revenue by Country (2025-2030) & (US$ Million) Table 181. Latin America Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024) & (US$ Million) Table 182. Latin America Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024) & (US$ Million) Table 183. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Country (2019-2024) & (US$ Million) Table 184. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Country (2025-2030) & (US$ Million) Table 185. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024) & (US$ Million) Table 186. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024) & (US$ Million) Table 187. Contract Pharmaceutical Manufacturing Key Raw Materials, Industry Status and Trend Table 188. Contract Pharmaceutical Manufacturing Key Raw Materials and Upstream Suppliers Table 189. Contract Pharmaceutical Manufacturing Clients Status and Trend Table 190. Contract Pharmaceutical Manufacturing Typical Clients Table 191. Contract Pharmaceutical Manufacturing Distributors Table 192. Contract Pharmaceutical Manufacturing Market Trends Table 193. Contract Pharmaceutical Manufacturing Market Drivers Table 194. Contract Pharmaceutical Manufacturing Market Challenges Table 195. Contract Pharmaceutical Manufacturing Market Restraints Table 196. Research Programs/Design for This Report Table 197. Key Data Information from Secondary Sources Table 198. Key Data Information from Primary Sources List of Figures Figure 1. Contract Pharmaceutical Manufacturing Product Picture Figure 2. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type in 2023 & 2030 Figure 3. Oral Product Picture Figure 4. Injectable Product Picture Figure 5. API Product Picture Figure 6. Other Product Picture Figure 7. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application in 2023 & 2030 Figure 8. Large Enterprise Figure 9. Small Medium Enterprise Figure 10. Contract Pharmaceutical Manufacturing Report Years Considered Figure 11. Global Contract Pharmaceutical Manufacturing Revenue, (US$ Million), 2019 VS 2023 VS 2030 Figure 12. Global Contract Pharmaceutical Manufacturing Market Size 2019-2030 (US$ Million) Figure 13. Global Contract Pharmaceutical Manufacturing Market Size Market Share by Region: 2023 Versus 2030 Figure 14. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Region (2019-2030) Figure 15. Contract Pharmaceutical Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023 Figure 16. Global Contract Pharmaceutical Manufacturing Revenue Market Share Forecast by Type (2019-2030) Figure 17. Global Contract Pharmaceutical Manufacturing Revenue Market Share Forecast by Application (2019-2030) Figure 18. North America Contract Pharmaceutical Manufacturing Revenue 2019-2030 (US$ Million) Figure 19. North America Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2019-2024) Figure 20. North America Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2019-2024) Figure 21. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue 2019-2030 (US$ Million) Figure 22. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue Market Share by Region (2019-2030) Figure 23. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2019-2024) Figure 24. Asia-Pacific Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2019-2024) Figure 25. Europe Contract Pharmaceutical Manufacturing Revenue Growth Rate 2019-2030 (US$ Million) Figure 26. Europe Contract Pharmaceutical Manufacturing Revenue Market Share by Country (2019-2030) Figure 27. Europe Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2019-2024) Figure 28. Europe Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2019-2024) Figure 29. Latin America Contract Pharmaceutical Manufacturing Revenue Growth Rate 2019-2030 (US$ Million) Figure 30. Latin America Contract Pharmaceutical Manufacturing Revenue Market Share by Country (2019-2024) Figure 31. Latin America Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2019-2024) Figure 32. Latin America Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2019-2024) Figure 33. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Growth Rate 2019-2030 (US$ Million) Figure 34. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Market Share by Country (2019-2030) Figure 35. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2019-2024) Figure 36. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2019-2024) Figure 37. Contract Pharmaceutical Manufacturing Supply Chain (Upstream and Downstream Market) Figure 38. Global Production Market Share of Contract Pharmaceutical Manufacturing Raw Materials by Region in 2023 Figure 39. Contract Pharmaceutical Manufacturing Distribution Channels Figure 40. Global Contract Pharmaceutical Manufacturing Percentage 2019-2030: Indirect Sales VS Direct Sales Figure 41. Global Contract Pharmaceutical Manufacturing Percentage 2019-2030: Online Sales VS Offline Sales Figure 42. Bottom-up and Top-down Approaches for This Report Figure 43. Data Triangulation Figure 44. Key Executives Interviewed Figure 45. Global Contract Pharmaceutical Manufacturing Percentage 2019-2030: Online Sales VS Offline Sales Figure 46. Bottom-up and Top-down Approaches for This Report Figure 47. Data Triangulation Figure 48. Key Executives Interviewed
